Search - tctmd.com

Displaying 801 - 820 of 923

Sort: Relevancy | Date

Presentation TCT 2014

Hemodynamics of Dynamic Obstruction

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Howard C. Herrmann, James B. Hermiller Jr

September 16, 2014

Presentation TCT 2014

Diagnostic Evaluation of Patients Referred with HCM Diagnosis

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Howard C. Herrmann, Rod H. Stables

September 16, 2014

Presentation TCT 2014

Epidemiology and Genetics

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Howard C. Herrmann, Carolyn Ho

September 16, 2014

Presentation TCT 2014

TCT 150: First-in-Man Experience with Transendocardial Injections of Bone Marrow-Derived Mesenchymal Stem Cells in Idiopathic Dilated Cardiomyopathy: The MYOCYTE Trial

Presenter: Marc S. Penn, Andreas M. Zeiher, Warren Sherman, Ricardo Sanz-Ruiz, MD

September 15, 2014

Presentation TCT 2014

CHF and Cardiomyopathy

Presenter: Greg L. Kaluza, Manish A. Parikh, Varinder P. Singh, Allen Jeremias

September 12, 2014

News Daily News

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

September 02, 2014

News Daily News

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

L.A. McKeown

August 20, 2014

News Daily News

Preprocedural Patient Factors Useful for Predicting Poor Outcome Following TAVR

L.A. McKeown

June 03, 2014

News Conference News EuroPCR 2014

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

Caitlin E. Cox

May 22, 2014

News Industry News

Biscayne Pharmaceuticals' GHRH Technology Featured In Presentations At International Society For Heart Research Meeting

May 14, 2014

News Industry News

Boston Scientific Reports Key Data at the 35th Annual Scientific Sessions of the Heart Rhythm Society

May 05, 2014

Presentation

Adipose-Derived Regenerative Cells in Patients with Ischemic Cardiomyopathy

Presenter: E.C. Perin

April 21, 2014

News Daily News

First-in-Man Study Demonstrates Safety, Feasibility of Adipose-Derived Cell Therapy for Heart Failure

April 21, 2014

Presentation Fellows 2014

Septal Ablation for HOCM

Presenter: Srihari Naidu

April 14, 2014

Presentation ECHO 2014

Hypertrophic Cardiomyopathy: Diagnosis and Management

Presenter: Mario J. Garcia

April 10, 2014

News Daily News

MADIT-CRT: Resynchronization Ups Survival in Patients with Mild Heart Failure and LBBB

Caitlin E. Cox

April 03, 2014

News Conference News ACC 2014

Intramyocardial Injection of Stem Cells Shows Promise for Severe Ischemic Heart Failure

Yael L. Maxwell

March 31, 2014

News Conference News ACC 2014

TAVR With the CoreValve Device Superior to Surgery at 1 Year

Yael L. Maxwell

March 29, 2014

Presentation

Long-term Survival after Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Presenter: Josef Veselka

February 06, 2014

News Daily News

Survival After Septal Ablation for HOCM Similar to General Population

L.A. McKeown

February 06, 2014

Advertisement

Hemodynamics of Dynamic Obstruction

Diagnostic Evaluation of Patients Referred with HCM Diagnosis

Epidemiology and Genetics

TCT 150: First-in-Man Experience with Transendocardial Injections of Bone Marrow-Derived Mesenchymal Stem Cells in Idiopathic Dilated Cardiomyopathy: The MYOCYTE Trial

CHF and Cardiomyopathy

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

Preprocedural Patient Factors Useful for Predicting Poor Outcome Following TAVR

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

Biscayne Pharmaceuticals' GHRH Technology Featured In Presentations At International Society For Heart Research Meeting

Boston Scientific Reports Key Data at the 35th Annual Scientific Sessions of the Heart Rhythm Society

Adipose-Derived Regenerative Cells in Patients with Ischemic Cardiomyopathy

First-in-Man Study Demonstrates Safety, Feasibility of Adipose-Derived Cell Therapy for Heart Failure

Septal Ablation for HOCM

Hypertrophic Cardiomyopathy: Diagnosis and Management

MADIT-CRT: Resynchronization Ups Survival in Patients with Mild Heart Failure and LBBB

Intramyocardial Injection of Stem Cells Shows Promise for Severe Ischemic Heart Failure

TAVR With the CoreValve Device Superior to Surgery at 1 Year

Long-term Survival after Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Survival After Septal Ablation for HOCM Similar to General Population

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content